Amin Shahrbaf, M., Samimi, M., Karimi, S., Salari, M., Ghaffari, M., Yazdanbakhsh, S., Najafian, A., Vosough, M. and Massood Nabavi, S. 2024. The first study of real-world efficacy and safety of Natalizumab (Tysabri®) in Iran. Trends in Immunotherapy. 8, 1 (Mar. 2024). DOI:https://doi.org/10.24294/ti.v8.i1.3920.